Correlation Between MediciNova and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both MediciNova and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Neoleukin Therapeutics, you can compare the effects of market volatilities on MediciNova and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Neoleukin Therapeutics.
Diversification Opportunities for MediciNova and Neoleukin Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between MediciNova and Neoleukin is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of MediciNova i.e., MediciNova and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between MediciNova and Neoleukin Therapeutics
Given the investment horizon of 90 days MediciNova is expected to generate 0.93 times more return on investment than Neoleukin Therapeutics. However, MediciNova is 1.07 times less risky than Neoleukin Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 215.00 in MediciNova on September 1, 2024 and sell it today you would lose (8.00) from holding MediciNova or give up 3.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.33% |
| Values | Daily Returns |
MediciNova vs. Neoleukin Therapeutics
Performance |
| Timeline |
| MediciNova |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
MediciNova and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Neoleukin Therapeutics
The main advantage of trading using opposite MediciNova and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| MediciNova vs. Cue Biopharma | MediciNova vs. Tff Pharmaceuticals | MediciNova vs. Lantern Pharma | MediciNova vs. Eliem Therapeutics |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |